Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global ...

Report found business relationships between telehealth and pharma companies may indirectly lead patients toward certain ...

Depo-Provera is a birth control shot that is injected every three months and features a type of progestin hormone called ...

Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced it will release its second quarter 2025 financial and ...

Pfizer witnessed a dramatic 45.77% surge in trading volume, reaching a staggering 11.97 billion shares. Pfizer's stock price ...

Boston conference will explore strategic partnering, device innovation, and delivery solutions for emerging therapeutics.

The global clinical nutrition market is set to witness a growth rate of 7% in the next 5 years. Increasing aging population ...

The global pediatric anticoagulant formulations market is valued at approximately $1.35 billion in 2024 and is projected to g ...

Sino Biopharma will acquire LaNova Medicines, which has licensed cancer drugs for Merck and AstraZeneca, for $951 million.

Detailed price information for Telescope Innovations Corp. (TELI-CN) from The Globe and Mail including charting and trades.

Detailed price information for Ascentage Pharma Group Intl ADR (AAPG-Q) from The Globe and Mail including charting and trades.